Navigation Links
Cyberonics Reports Strong Fiscal 2010 First Quarter Results
Date:8/19/2009

trical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com.

Safe harbor statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the use of forward-looking terminology, including "may," "believe," "will," "expect," "anticipate," "estimate," "plan," "intend," "forecast," or other similar words. Statements contained in this press release are based on information presently available to us and assumptions that we believe to be reasonable. We are not assuming any duty to update this information if those facts change or if we no longer believe the assumptions to be reasonable. Investors are cautioned that all such statements involve risks and uncertainties, including without limitation, statements concerning obtaining regulatory approval in Japan for the epilepsy indication, maintaining leadership in the epilepsy device market, successfully developing a product capable of seizure detection, seizure recording and responsive stimulation, fiscal 2010 sales of $157 million to $161 million, and fiscal 2010 operating income of $24 million to $27 million. Our actual results may differ materially. Important factors that may cause actual results to differ include, but are not limited to: continued market acceptance of VNS Therapy(TM) and sales of our product; the development and satisfactory completion of clinical trials and/or market test and/or regulatory approval of VNS Therapy(TM) for the treatment of other indications; satisfactory completion of post-market studies required by the U.S. Food and Drug Administration as a condition of approval for the treatmen
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference
2. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
3. Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan
4. Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
5. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results
6. Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter
7. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results
8. Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development
9. Cyberonics to Present at Piper Jaffray 20th Annual Health Care Conference
10. Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
11. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... New and more complex medicines ... manufacturers, payers, pharmacists and patients. Now Specialty Pharmacy ... partnering with the National Association of Specialty Pharmacy ... to this developing field to better equip pharmacy ... , “This partnership creates a powerful platform for ...
(Date:4/28/2015)... 28, 2015 Celebrating women has become a ... be the third year that all things mom and female ... Hands On is offering some great specials Special ... of the year could there be to focus on woman," ... pampering and this is a terrific time for it. And ...
(Date:4/28/2015)... 28, 2015 SeniorCare.com has published the ... the reality problem Americans have regarding aging and long-term ... long-term care services as they age, 63% of Americans ... , In the report, Carol Marak of SeniorCare.com interviewed ... American Health Care Association and The Scan Foundation. The ...
(Date:4/28/2015)... Once considered an unproven alternative to HID lighting, the ... storm with perfectly tailored light spectrums in an ideal, low ... than half of every SuperCloset and SuperRoom sold are now ... is gone and LED Grow Lights are here to stay. ... their first hand experience using the new LED Grow lights ...
(Date:4/28/2015)... The west coast, south, east coast, ... areas that healthcare professionals searched for jobs through the ... of March 2015. Data was released by the ... jobs , physical therapy jobs , and other ... health fields. , States with the most ...
Breaking Medicine News(10 mins):Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Commack Massage Therapy and Wellness Day Spa Dedicates Time To Celebrate Women 2Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:Hot States for Medical Careers: Healthcare Staffing Agency Aureus Medical Releases Online Search Results 2
... genetic factors and drug abuse saying that genetic tendencies play ... ,Dr. Kenneth S. Kendler, who has led the ... the importance of genetic factors in a culture/country (Norway) with ... that in such countries, social rather than genetics factors should ...
... When the body's arteries, veins and capillaries become diseased, ... the possibility of stroke and heart attack.// Dennis Gable, ... Baylor Regional Medical Center at Plano, provides information about ... ,Varicose veins: ,Varicose veins are large, twisted, swollen ...
... person dying of coronary heart disease can be predicted by ... venules in the eyes. ,Arterioles and venules are ... reflects the general state of the smaller blood vessels in ... of the study, 78 women (just over 4%) and 114 ...
... be a wake up call to get the duvets washed and ... their duvets even in six months, and these could// be the ... ,A survey conducted in many households revealed that two ... months. The dust mites and filth are potential health hazards ...
... have said one therapeutic dose of radiation resulted in mice ... ,Research in US have indicated, in a study ... Physiology that mice that has received a single therapeutic dose ... of radiation received by human cancer patients lost as much ...
... NHS has launched National Transplant Week to raise awareness of ... take place and the number of people// awaiting transplants. ... population in Britain has joined the Organ Donor Register. In ... on transplant lists, only 2,200 actually operations took place. ...
Cached Medicine News:Health News:Vascular Disease 101: Discovering and Treating Common Diseases of the Veins 2Health News:National Transplant Week to Raise Need for Organ Donation 2
(Date:4/28/2015)... 2015  Shares of Celladon Corp. (NASDAQ: CLDN ... the announcement of poor drug trial results of the phase ... agent, MYDICAR.  The selloff may be warranted or it ... bargain basement prices. An analyst report update ... pipeline, financial review, analyst summary, valuation, and recommendation can ...
(Date:4/28/2015)... Israel , April 28, 2015 ... in its sixth funding cycle for U.S.- Israel ... and Energy Efficiency. To be considered, a project ... between a company and a university/research institution (one from the ... proposal should have significant commercial potential and the project outcome ...
(Date:4/27/2015)... Techpool Bio-Pharma Co has experienced tremendous changes in ... chief executive officer, transforming from a traditional private Chinese company ... took office in 2011, he was the senior executive ... and Eisai, with more than 20 years successful management experience ... Asia-Pacific region. "I chose Techpool ...
Breaking Medicine Technology:Examining what's Left after MYDICAR Drug Trial Ends In Failure; Celladon Corp. Analyst Report Issued by BrokerBank Securities, Inc. 2Opportunities for Funding U.S.-Israel Cooperation for Renewable Energy and Efficiency 2Techpool Transforms Into International Player 2Techpool Transforms Into International Player 3
... 9, 2011 NeurogesX, Inc. (Nasdaq: NGSX ... novel pain management therapies, today announced it will hold ... p.m. ET (1:30 p.m. PT) to provide an update ... patch for the management of neuropathic pain associated with ...
... Misonix, Inc. (Nasdaq: MSON ), ... markets innovative, therapeutic, ultrasonic products worldwide for wound ... surgical and medical applications, today reported financial results ... ending December 31, 2010.  Michael A. McManus Jr., ...
Cached Medicine Technology:NeurogesX to Provide Qutenza® Launch Update 2NeurogesX to Provide Qutenza® Launch Update 3NeurogesX to Provide Qutenza® Launch Update 4Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 2Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 3Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 4Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 5Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: